On April 23, 2020, the Centers for Medicare & Medicaid Services (CMS) released the “State Medicaid & CHIP Telehealth Toolkit: Policy Considerations for States Expanding Use of Telehealth” (the Toolkit). Telehealth allows patients to receive necessary health care services without risking the spread of COVID-19 through in-person interactions. The Toolkit is one of several guidance documents CMS has issued to expand use of telehealth during the COVID-19 pandemic. As discussed previously, CMS has expanded coverage of telehealth services for all Medicare beneficiaries, allowing practitioners to treat patients (whether new or established) via telehealth, and allowing telephone only services in various circumstances.
However, because federal and state governments dually fund Medicaid as a state-administered program, and each state designs its own program (subject to CMS approval for federal funding), it is not practical for CMS to issue sweeping waivers on telehealth services applicable to all states. Medicaid covers 71 million Americans, including 35 million children, and Medicaid may become an even more important safety net due to the economic implications of the COVID-19 pandemic. Consequently, the Toolkit aims to help states expand Medicaid telehealth coverage by identifying existing state policies that may impede the use of telehealth. Below we summarize some key points from the Toolkit, but refer interested parties to review the Toolkit in full.
The Toolkit describes telehealth as a “mix of four interrelated domains” and provides questions that states should consider for each domain in order to minimize barriers to telehealth utilization. The four domains include:
The population to whom service is being delivered. States may have policies in place that limit telehealth coverage to certain populations like residents of rural areas, for instance. States have the flexibility to cover telehealth services across patient populations. The Toolkit directs states to consider the following questions, among others, when assessing policies that restrict the population who have access to telehealth:
The service that is being delivered, including coverage and reimbursement. Historically, a number of states have covered only a limited number of services when provided via telehealth, including behavioral health services, for instance. Moreover, an American Telemedicine Association report found that only twenty-eight states have adopted Medicaid payment parity between telehealth and in-person services. States lacking payment parity laws may unduly restrict the ability for telehealth to facilitate increased access to care. States should consider the following:
The practitioner delivering the service. State scope of practice laws may limit which practitioners can deliver services via telehealth. For instance, states may authorize some practitioners including obstetricians, gynecologists, dentists, and physical and occupational therapists to bill Medicaid, but state scope of practice laws may prohibit these practitioners from providing services via telehealth. States should consider the following:
The technology used to deliver the service. Practitioners may deliver telehealth via various means, and states often regulate provision of telehealth services by requiring a specific modality. For instance, two-way audio/visual communication, store and forward, and remote patient monitoring are three possible modalities. However, CMS and many private payors have relaxed or waived telehealth modality requirements in an effort to increase access to telehealth services. For instance, some payer policies allow the use of audio-only communication in limited circumstances during the COVID-19 pandemic. States should consider the following when analyzing expansion of telehealth coverage:
The Toolkit also discusses provision of telehealth services to pediatric patients. For instance, state policies, including consent and privacy laws may impede access to telehealth for pediatric patients. State consent laws may require parental consent for children utilizing telehealth services, or new consent and re-consent in some situations. Moreover, states should consider whether credentialing and licensure requirements for pediatric practitioners present a barrier to telehealth utilization.
Finally, the Toolkit answers frequently asked questions (FAQs) in the area of Medicaid/CHIP benefit, financing, workforce, managed care and health information exchange flexibilities. Largely, these FAQs highlight guidance previously issued by CMS or flexibilities established by existing federal statutes and regulations.
The State Medicaid & CHIP Telehealth Toolkit represents CMS’s continuing effort to ensure access to necessary health care services despite disruptions due to the COVID-19 pandemic. By considering the questions posed in the Toolkit, states may identify the regulatory and policy barriers that restrict telehealth utilization and take action to limit these barriers and, in turn, increase access care.